Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 8246 [2024-02255]
Download as PDF
<![CDATA[
8246
Federal Register / Vol. 89, No. 25 / Tuesday, February 6, 2024 / Notices
productive and potentially productive
portions of the Permian Basin.
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Cooperative Research
Group H2ICE Demonstration Vehicle
(‘‘H2ICE’’)
Notice is hereby given that, on
December 5, 2023, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Cooperative Research Group H2ICE
Demonstration Vehicle (‘‘H2ICE’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Daimler Truck North
America LLC, Portland, OR, has been
added as a party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and H2ICE
intends to file additional written
notifications disclosing all changes in
membership.
On August 14, 2023, H2ICE filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on November 20, 2023 (88 FR
80763).
ddrumheller on DSK120RN23PROD with NOTICES1
[FR Doc. 2024–02251 Filed 2–5–24; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
18:15 Feb 05, 2024
Jkt 262001
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
[FR Doc. 2024–02279 Filed 2–5–24; 8:45 am]
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
DEPARTMENT OF JUSTICE
Notice is hereby given that, on
January 9, 2024, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), Medical
Technology Enterprise Consortium
(‘‘MTEC’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Act Medical, Ltd.,
Loughborough, GREAT BRITIAN;
Affinity Associates LLC, Holden Beach,
NC; Akthelia, Reykjavik, ICELAND;
Altra, Inc., Las Vegas, NV; Amazon Web
Services, Arlington, VA; AutoMedicus
Corp., Pasadena, CA; AutonomUS
Medical Technologies, Inc., Cambridge,
MA; Collabralink Technologies, Inc.,
dba Groundswell, McLean, VA;
Compression Works, Inc., Birmingham,
AL; Convergent Clinical, Inc., Carlsbad,
CA; DesiCorp, Inc., Louisville, KY;
Digital Velocity Partners LLC, Chevy
Chase, MD; Duquesne University of the
Holy Spirit, Pittsburgh, PA; E4
Technology, Inc., Huntsville, AL;
Elemance LLC, Winston Salem, NC;
Endpoint Health, Palo Alto, CA;
Epineuron Technologies, Inc.,
Mississauga, CANADA; First Nation
Group LLC, Niceville, FL; Fistula
Solution Corp., Scandia, MN; Global
Resonance Technologies LLC,
Shelburne, VT; Grande Delta Corp.,
Alameda, CA; GrayMatters Health Ltd.,
Haifa, ISRAEL; Halomine, Inc., Ithaca,
NY; International Scientific Advisors,
Inc. dba MilMed Connect, Beaverton,
OR; JDSAT, Inc., Mclean, VA; JLM
ExoGrade LLC, Austin, TX;
KardioGenics, Inc., San Jose, CA; Legacy
US, Inc., Boise, ID; Longhorn Vaccines
and Diagnostics LLC, Bethesda, MD;
Longhorn Vaccines and Diagnostics
LLC, Bethesda, MD; MedStar Health
Research Institute, Inc., Hyattsville, MD;
Muscle Activation Techniques,
Englewood, CO; Nuream, Inc.,
Wilmington, NC; NZ Technologies, Inc.,
Vancouver, CANADA; Padagis US LLC,
Allegan, MI; Physcient Surgical, Inc.,
Durham, NC; Powerboard Life Systems,
Inc., San Francisco, CA; ppx-TEC LLC,
Jackson, MS; RedC Biotech, Ltd., Bnei
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
Zion, ISRAEL; RESDEF, Inc., Chicago,
IL; Sigma Genetics, Inc. Seattle, WA;
Soar Technology LLC, Ann Arbor, MI;
Sperry Bio, Inc., Springfield, VT;
Sterogene Bioseparations, Inc., Carlsbad,
CA; Sutton’s Creek, Westlake, CA;
Syracuse University, Syracuse, NY;
Tachmed, Inc., New York, NY; Texas
Christian University, Fort Worth, TX;
The Huntsman Mental Health
Foundation, Salt Lake City, UT; Turner
Imaging Systems, Orem, UT; University
of Alabama, Huntsville, Huntsville, AL;
University of Chicago, Chicago, IL;
University of Texas Southwestern
Medical Center, Dallas, TX; Vascarta
Inc., Short Hills, NJ; Vaxart, Inc., South
San Francisco, CA; Vaxxas, Cambridge,
MA; Verndari, Inc., Rancho, Cordova,
CA; Vigor Medical Technologies, Ltd.,
Haifa, ISRAEL; Virpax Pharmaceuticals,
Inc., Berwyn, PA; Vivosang, Inc., Santa
Fe, NM; and Xtory, Inc., Arlington, MA,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014, MTEC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on June 9, 2014 (79 FR 32999).
The last notification was filed with
the Department on October 2, 2023. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 15, 2023 (88 FR
86932).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–02255 Filed 2–5–24; 8:45 am]
BILLING CODE
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Open Grid Alliance, Inc.
Notice is hereby given that, on
November 16, 2023, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), Open
Grid Alliance, Inc. (‘‘OGA’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
E:\FR\FM\06FEN1.SGM
06FEN1
]]>Agencies
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Page 8246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02255]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on January 9, 2024, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology
Enterprise Consortium (``MTEC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, Act Medical, Ltd., Loughborough, GREAT
BRITIAN; Affinity Associates LLC, Holden Beach, NC; Akthelia,
Reykjavik, ICELAND; Altra, Inc., Las Vegas, NV; Amazon Web Services,
Arlington, VA; AutoMedicus Corp., Pasadena, CA; AutonomUS Medical
Technologies, Inc., Cambridge, MA; Collabralink Technologies, Inc., dba
Groundswell, McLean, VA; Compression Works, Inc., Birmingham, AL;
Convergent Clinical, Inc., Carlsbad, CA; DesiCorp, Inc., Louisville,
KY; Digital Velocity Partners LLC, Chevy Chase, MD; Duquesne University
of the Holy Spirit, Pittsburgh, PA; E4 Technology, Inc., Huntsville,
AL; Elemance LLC, Winston Salem, NC; Endpoint Health, Palo Alto, CA;
Epineuron Technologies, Inc., Mississauga, CANADA; First Nation Group
LLC, Niceville, FL; Fistula Solution Corp., Scandia, MN; Global
Resonance Technologies LLC, Shelburne, VT; Grande Delta Corp., Alameda,
CA; GrayMatters Health Ltd., Haifa, ISRAEL; Halomine, Inc., Ithaca, NY;
International Scientific Advisors, Inc. dba MilMed Connect, Beaverton,
OR; JDSAT, Inc., Mclean, VA; JLM ExoGrade LLC, Austin, TX;
KardioGenics, Inc., San Jose, CA; Legacy US, Inc., Boise, ID; Longhorn
Vaccines and Diagnostics LLC, Bethesda, MD; Longhorn Vaccines and
Diagnostics LLC, Bethesda, MD; MedStar Health Research Institute, Inc.,
Hyattsville, MD; Muscle Activation Techniques, Englewood, CO; Nuream,
Inc., Wilmington, NC; NZ Technologies, Inc., Vancouver, CANADA; Padagis
US LLC, Allegan, MI; Physcient Surgical, Inc., Durham, NC; Powerboard
Life Systems, Inc., San Francisco, CA; ppx-TEC LLC, Jackson, MS; RedC
Biotech, Ltd., Bnei Zion, ISRAEL; RESDEF, Inc., Chicago, IL; Sigma
Genetics, Inc. Seattle, WA; Soar Technology LLC, Ann Arbor, MI; Sperry
Bio, Inc., Springfield, VT; Sterogene Bioseparations, Inc., Carlsbad,
CA; Sutton's Creek, Westlake, CA; Syracuse University, Syracuse, NY;
Tachmed, Inc., New York, NY; Texas Christian University, Fort Worth,
TX; The Huntsman Mental Health Foundation, Salt Lake City, UT; Turner
Imaging Systems, Orem, UT; University of Alabama, Huntsville,
Huntsville, AL; University of Chicago, Chicago, IL; University of Texas
Southwestern Medical Center, Dallas, TX; Vascarta Inc., Short Hills,
NJ; Vaxart, Inc., South San Francisco, CA; Vaxxas, Cambridge, MA;
Verndari, Inc., Rancho, Cordova, CA; Vigor Medical Technologies, Ltd.,
Haifa, ISRAEL; Virpax Pharmaceuticals, Inc., Berwyn, PA; Vivosang,
Inc., Santa Fe, NM; and Xtory, Inc., Arlington, MA, have been added as
parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on October 2,
2023. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on December 15, 2023 (88 FR 86932).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-02255 Filed 2-5-24; 8:45 am]
BILLING CODE
